ATE286507T1 - Dna kodierend für das strukturalprotein-1 vom infektiösen lachs anämie virus und ihre verwendungen - Google Patents

Dna kodierend für das strukturalprotein-1 vom infektiösen lachs anämie virus und ihre verwendungen

Info

Publication number
ATE286507T1
ATE286507T1 AT00203555T AT00203555T ATE286507T1 AT E286507 T1 ATE286507 T1 AT E286507T1 AT 00203555 T AT00203555 T AT 00203555T AT 00203555 T AT00203555 T AT 00203555T AT E286507 T1 ATE286507 T1 AT E286507T1
Authority
AT
Austria
Prior art keywords
structural protein
dna coding
infectious salmon
anemia virus
protein
Prior art date
Application number
AT00203555T
Other languages
English (en)
Inventor
Erik Biering
Bjorn Krossoy
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE286507(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE286507T1 publication Critical patent/ATE286507T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/108—Orthomyxoviridae (F), e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00203555T 1999-10-18 2000-10-12 Dna kodierend für das strukturalprotein-1 vom infektiösen lachs anämie virus und ihre verwendungen ATE286507T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99203401 1999-10-18

Publications (1)

Publication Number Publication Date
ATE286507T1 true ATE286507T1 (de) 2005-01-15

Family

ID=8240749

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00203555T ATE286507T1 (de) 1999-10-18 2000-10-12 Dna kodierend für das strukturalprotein-1 vom infektiösen lachs anämie virus und ihre verwendungen

Country Status (10)

Country Link
US (1) US6471964B1 (de)
EP (1) EP1094069B2 (de)
JP (1) JP4777508B2 (de)
AT (1) ATE286507T1 (de)
AU (1) AU778791B2 (de)
CA (1) CA2321437A1 (de)
DE (1) DE60017229D1 (de)
DK (1) DK1094069T4 (de)
NO (1) NO330866B1 (de)
NZ (1) NZ507530A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60029327T2 (de) * 1999-08-07 2007-07-05 Novartis Ag Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
EP1263781B1 (de) * 2000-03-08 2006-11-22 The University Court of The University of Aberdeen Virusantigene und impfstoff gegen infektiöses lachsanämievirus
CA2393895A1 (en) * 2001-07-17 2003-01-17 University Of Prince Edward Island Serological test for isav in fish
DE60239753D1 (de) * 2001-10-19 2011-05-26 Intervet Int Bv Impfstoff gegen infektiöses lachsanämievirus
TWI350310B (en) 2002-12-13 2011-10-11 Novartis Ag Immunization of fish with plant-expressed recombinant proteins
CA2687208C (en) 2006-12-22 2017-02-14 Soluciones Biotecnologicas Innovacion Ltda Process and formulation for immunizing fish in aquaculture systems
EP2482825B1 (de) 2009-10-02 2016-11-23 The Trustees of Columbia University in the City of New York Diagnostische fisch-reoviren-zusammensetzungen
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59610384D1 (de) * 1995-10-18 2003-05-28 Bayer Cropscience Ag Iminoessigsäureamide und ihre verwendung als schädlingsbekämpfungsmittel
EP0839913B1 (de) * 1996-11-04 2006-06-21 Ottawa Health Research Institute Verfahren zur Expression von Polypeptide in Fishen durch wässerung in DNS enthaltende Lösung
KR20010032336A (ko) * 1997-11-21 2001-04-16 브랑디 빠스깔 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
DE60029327T2 (de) * 1999-08-07 2007-07-05 Novartis Ag Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe

Also Published As

Publication number Publication date
NO20005217L (no) 2001-04-19
AU6653800A (en) 2001-04-26
JP4777508B2 (ja) 2011-09-21
CA2321437A1 (en) 2001-04-18
DK1094069T3 (da) 2005-05-17
AU778791B2 (en) 2004-12-23
NO20005217D0 (no) 2000-10-17
DE60017229D1 (de) 2005-02-10
US6471964B1 (en) 2002-10-29
DK1094069T4 (da) 2008-07-21
EP1094069B1 (de) 2005-01-05
NO330866B1 (no) 2011-08-01
JP2001211888A (ja) 2001-08-07
EP1094069A1 (de) 2001-04-25
EP1094069B2 (de) 2008-04-23
NZ507530A (en) 2001-08-31

Similar Documents

Publication Publication Date Title
ATE329616T1 (de) Virale nukleotidsequenz vr-2332 und nutzungsverfahren
CA2005291A1 (en) Feline infectious peritonitis virus diagnostic tools
ATE257175T1 (de) Rekombinantes infektiöses nicht-in-segmente- geteiltes, negativ-strange-rns-virus
DE69839557D1 (de) Klonierte genome von infektiösen hepatitis c viren und deren verwendungen
DE60043299D1 (de) Proteinfragmente die polyepitope des nef proteins von hiv umfassen, deren herstellung und verwendungen insbesondere zur impfung
CY1109725T1 (el) Ειδικες δεσμευομενες πρωτεϊνες και χρησεις αυτων
CA2096159A1 (en) Peptides that induce antibodies which neutralize genetically divergent hiv-1 isolates
DE60017229D1 (de) DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen
PT1219711E (pt) Vacina de lawsonia intracellularis
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
DE60034884D1 (de) Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
HK1052532A1 (zh) α(2)巨球蛋白受體作為熱沖擊蛋白受體及其用途
ATE332712T1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
DE60041042D1 (de) Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon
CY1110861T1 (el) Μορια νουκλεϊνικων οξεων toy hdv, θραυσματα αυτων και εφαρμογες αυτων
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
NO20041564L (no) Infeksios lakse anemi-virus vaksine
WO2002095413A3 (en) Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
WO1998042847A3 (de) Papillomvirus-hauptcapsid-proteins und deren verwendung in diagnose, therapie und vakzinierung
WO2004027066A3 (fr) Protéine recombinante chimérique et diagnostic in vitro du hiv
WO2002036733A3 (en) Cd36 as a heat shock protein receptor and uses thereof
WO2002026784A3 (en) Matrix proteins m1 and m2 of infections salmon anaemia virus
Simpson et al. Antigenic proteins of Borrelia burgdorferi
ATE368117T1 (de) Komplette gensequenz des esel-leukozyten- impfstoffstammes des equinen infektiösen anemievirus und ihre anwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties